Taysha's Chief Sold $1.2: What It Means for Investors
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
User feedback can provide valuable insights into no fee travel points cards. Discover what real users are saying to make an informed choice.
16,799 articlesAn insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
A 61-year-old CEO at a major U.S. insurer shapes a six-day workout schedule, guided by his 23-year-old son, while ste...
A family-run frozen-food business has turned nostalgia into a nationwide snack hit, shipping 20 million soup dumpling...
Global worker engagement remains stuck near crisis levels, even as AI and remote work reshape the office. This story ...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
A CRMLS survey of agents who closed deals this year shows broad backing for the MLS Clear Cooperation policy, with st...
A Chinese open-weights AI model stirred markets and sent Nvidia shares lower. This piece explains why the dip could a...
RE/MAX brokers are turning to repeatable systems over lofty goals to push growth amid market shifts, with panels at R...
Under Armour CEO Kevin Plank reiterates a belief in targeted micromanagement to speed product cycles in a volatile re...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
The Bank of England unveiled a tokenization agenda and a framework for systemic sterling stablecoins, with a two-stag...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...